Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial is a research paper published in The Pharmacogenomics Journal (2015). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: R01 HL090997
NHLBI NIH HHS
Grant: U01 HL077826
NCATS NIH HHS
Grant: UL1 TR000073
NCRR NIH HHS
Grant: UL1RR025752
NHLBI NIH HHS
Grant: U01 HL077823
NHLBI NIH HHS
Grant: U01 HL077821
National Institutes of Health
Grant: 1U01HL077826-01
Data Coordinating Center for IMMEDIATE Trial
National Institutes of Health
Grant: 5R01HL090997-04
Genetic Markers of GIK Effect in Acute Coronary Syndrome in the IMMEDIATE Trial
National Institutes of Health
Grant: 1ZIATR000073-06
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes
National Institutes of Health
Grant: 3UL1RR025752-02S4
TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCA
National Institutes of Health
Grant: 5U01HL077821-02
Early EMS and ED Use of GIK for ACS: The IMMEDIATE Trial
National Institutes of Health
Grant: 1U01HL077823-01
LV Function Assessment Core Lab for IMMEDIATE Trial
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals